← Evidence map

ArticleESC heart failure2023

Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease.

Chang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36369767